Vázquez, Ramiro <br/><br/>
Promising in vivo efficacy of the BET bromodomain inhibitor OTX015/MK-8628 in malignant pleural mesothelioma xenografts.  [electronic resource] 

 -  International journal of cancer  Jan 2017 
 - 197-207 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1097-0215 
<br/><br/><label>Standard No.: </label>10.1002/ijc.30412  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetanilides--administration & dosage<br/>Aged<br/>Animals<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Cell Survival--drug effects<br/>Cisplatin--administration & dosage<br/>Deoxycytidine--administration & dosage<br/>Down-Regulation<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Heterocyclic Compounds, 3-Ring--administration & dosage<br/>Humans<br/>Lung Neoplasms--drug therapy<br/>Male<br/>Mesothelioma--drug therapy<br/>Mesothelioma, Malignant<br/>Mice<br/>Middle Aged<br/>Pemetrexed--administration & dosage<br/>Proto-Oncogene Proteins c-myc--metabolism<br/>Xenograft Model Antitumor Assays<br/>Gemcitabine